Avenir Corp Cytosorbents Corp Put Options Transaction History
Avenir Corp
- $948 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding CTSO
# of Institutions
58Shares Held
15.7MCall Options Held
16KPut Options Held
0-
Skylands Capital, LLC2.78MShares$3.2 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.24 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.93 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.44 Million0.18% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.2MShares$1.39 Million0.05% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $50.1M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...